These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 5486480)

  • 21. Concurrent chemoradiotherapy incorporating high-dose rate brachytherapy for locally advanced cervical carcinoma: survival outcomes, patterns of failure, and prognostic factors.
    Teh J; Yap SP; Tham I; Sethi VK; Chua EJ; Yeo R; Ho TH; Tay EH; Chia YN; Soh LT; Khoo-Tan HS
    Int J Gynecol Cancer; 2010 Apr; 20(3):428-33. PubMed ID: 20375809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Can hormone replacement therapy be used following treatment for gynecologic malignancies?].
    Gao YL; Zhu JQ
    Zhonghua Zhong Liu Za Zhi; 2012 Sep; 34(9):719-20. PubMed ID: 23159090
    [No Abstract]   [Full Text] [Related]  

  • 23. Phase II Study of Concurrent Chemoradiotheapy Using Nedaplatin for Locally Advanced Uterine Cervical Carcinoma (KGROG0501): Final Results.
    Niibe Y; Onda T; Matsuo K; Inoue Y; Hayakawa K
    Anticancer Res; 2017 Dec; 37(12):6983-6988. PubMed ID: 29187484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunocytology of cancer.
    Davidsohn I; Ni LY
    Acta Cytol; 1970 May; 14(5):276-82. PubMed ID: 4935158
    [No Abstract]   [Full Text] [Related]  

  • 25. [The study of ovarian metastasis in uterine cancer].
    Aida H; Kodama S; Aoki Y; Shimizu K; Honma S; Kanazawa K; Tanaka K
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 Mar; 44(3):315-22. PubMed ID: 1607754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparison of uterine artery chemoembolization and internal iliac arterial infusion chemotherapy for the combining treatment for women with locally advanced cervical cancer].
    Yu L; Tan GS; Xiang XH; Guo WB; Li HP; Huang YH; Yang JY
    Ai Zheng; 2009 Apr; 28(4):402-7. PubMed ID: 19622301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adjuvant therapy after radical surgery for stage IB-IIB cervical adenocarcinoma with risk factors.
    Seki T; Tanabe H; Nagata C; Suzuki J; Suzuki K; Takano H; Isonishi S; Ochiai K; Takakura S; Okamoto A
    Jpn J Clin Oncol; 2017 Jan; 47(1):32-38. PubMed ID: 27677664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dual-specific T cells combine proliferation and antitumor activity.
    Kershaw MH; Westwood JA; Hwu P
    Nat Biotechnol; 2002 Dec; 20(12):1221-7. PubMed ID: 12415288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Individualization of treatment based on biological behavior in uterine cervical cancer].
    Teshima K; Yamamoto K; Noda K
    Gan To Kagaku Ryoho; 1986 Sep; 13(9):2726-33. PubMed ID: 3753021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical experiences with microwave hyperthermia by newly developed small applicators in combination with radiotherapy].
    Jo S; Hiraoka M; Akuta K; Takahashi M; Abe M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1985 May; 45(5):711-6. PubMed ID: 4047929
    [No Abstract]   [Full Text] [Related]  

  • 31. [Immunotherapy of experimental colonic cancer: immunologic enhancement of grafted tumor].
    Martin MS; Martin F; Lagneau A; Horiot JC; Chomono R
    Biol Gastroenterol (Paris); 1974; 7(4):249-52. PubMed ID: 4464986
    [No Abstract]   [Full Text] [Related]  

  • 32. Radical surgery combined with radiotherapy in the treatment of cervical carcinoma.
    Nieminen U; Mattsson T; Widholm O
    Ann Chir Gynaecol Fenn; 1974; 63(2):134-40. PubMed ID: 4854004
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of stage I carcinoma of the cervix.
    Park RC; Patow WE; Rogers RE; Zimmerman EA
    Obstet Gynecol; 1973 Jan; 41(1):117-22. PubMed ID: 4682607
    [No Abstract]   [Full Text] [Related]  

  • 34. Combined radiologic-operative therapy in the treatment of cervical malignancy.
    Stage AH; Crawford EJ; Robinson LS; Brooks GG
    Am J Obstet Gynecol; 1974 Dec; 120(7):960-8. PubMed ID: 4429113
    [No Abstract]   [Full Text] [Related]  

  • 35. The immunotherapy of cancer.
    Parker CW
    Pharmacol Rev; 1973 Jun; 25(2):325-42. PubMed ID: 4581047
    [No Abstract]   [Full Text] [Related]  

  • 36. Doppler Ultrasound Flow Evaluation of the Uterine Arteries Significantly Correlates with Tumor Size in Cervical Cancer Patients.
    Bolla D; In-Albon S; Papadia A; Di Naro E; Gasparri ML; Mueller MM; Raio L
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S959-63. PubMed ID: 26036189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical statistics of gynecologic cancers in Japan.
    Yamagami W; Nagase S; Takahashi F; Ino K; Hachisuga T; Aoki D; Katabuchi H
    J Gynecol Oncol; 2017 Mar; 28(2):e32. PubMed ID: 28198168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ovarian preservation in locally advanced cervical cancer undergoing neoadjuvant chemotherapy and radical surgery.
    Signorelli M; Bogani G; Chiappa V; Ditto A; Scaffa C; Martinelli F; Lorusso D; Raspagliesi F
    Minerva Ginecol; 2018 Aug; 70(4):357-363. PubMed ID: 29600835
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Late recurrence in carcinoma of the cervix.
    Van Herik M; Decker DG; Lee RA; Symmonds RE
    Am J Obstet Gynecol; 1970 Dec; 108(8):1183-6. PubMed ID: 5482853
    [No Abstract]   [Full Text] [Related]  

  • 40. The prognostic factors for locally advanced cervical cancer patients treated by intensity-modulated radiation therapy with concurrent chemotherapy.
    Chen CC; Wang L; Lin JC; Jan JS
    J Formos Med Assoc; 2015 Mar; 114(3):231-7. PubMed ID: 25777974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.